相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
Xiao-Shan Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Michael A. Vogelbaum et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Hisashi Saji et al.
LANCET (2022)
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline
Vinai Gondi et al.
PRACTICAL RADIATION ONCOLOGY (2022)
Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study
Sebastian M. Christ et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABRCOMET-10 Randomized Trial
Samaher Ashram et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).
Steven J. Chmura et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Rohan R. Katipally et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option
Martin Faehling et al.
EUROPEAN JOURNAL OF CANCER (2021)
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
Daniel Buergy et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study
Monika Blake-Cerda et al.
LUNG CANCER (2021)
Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
Michael Dohopolski et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis
Lorenzo Spaggiari et al.
LUNG CANCER (2021)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
E. Le Rhun et al.
ANNALS OF ONCOLOGY (2021)
Radiation Toxicity in Patients With Collagen Vascular Disease: A Meta-Analysis of Case-Control Studies
Parvez M. Shaikh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases
Yilin Cao et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Imaging and its Impact on Defining the Oligometastatic State
Ali Pirasteh et al.
SEMINARS IN RADIATION ONCOLOGY (2021)
Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
Luca Bertolaccini et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non-small Cell Lung Cancer
Haruhisa Matsuguma et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
A Primer on Interstitial Lung Disease and Thoracic Radiation
Christopher D. Goodman et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases A Review
Rachel M. Glicksman et al.
JAMA ONCOLOGY (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer
Thierry Berghmans et al.
LUNG CANCER (2020)
Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases
Takaya Yamamoto et al.
CANCER MEDICINE (2020)
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study
Anastasia Chalkidou et al.
LANCET ONCOLOGY (2020)
Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations
Fang Hu et al.
CLINICAL LUNG CANCER (2019)
M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome
Hyesun Park et al.
ONCOLOGIST (2019)
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study
Oscar Arrieta et al.
LUNG CANCER (2019)
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT
Juliane Hoerner-Rieber et al.
CLINICAL LUNG CANCER (2019)
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial
Joshua M. Bauml et al.
JAMA ONCOLOGY (2019)
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report
Anne-Marie C. Dingemans et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Treatment Options for Adults With Multiple Metastatic Brain Tumors
Mario Ammirati et al.
NEUROSURGERY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors
Laurie E. Gaspar et al.
NEUROSURGERY (2019)
Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients
Takuya Aoki et al.
RESPIRATORY RESEARCH (2019)
Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline
Samuel T. Chao et al.
NEUROSURGERY (2018)
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group
Nandita M. deSouza et al.
EUROPEAN JOURNAL OF CANCER (2018)
Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer
W. Jeffrey Petty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis
Julian C. Hong et al.
PLOS ONE (2018)
Prognostic factors of oligometastatic non-small cell lung cancer: a meta-analysis
Shangbiao Li et al.
JOURNAL OF THORACIC DISEASE (2018)
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer A Phase 2 Randomized Clinical Trial
Puneeth Iyengar et al.
JAMA ONCOLOGY (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)
Dirk De Ruysscher et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysis
Fausto Petrelli et al.
LUNG CANCER (2018)
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
Daniel E. Spratt et al.
LANCET ONCOLOGY (2017)
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer
Matthias Guckenberger et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysis
Dianhe Li et al.
JOURNAL OF THORACIC DISEASE (2017)
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists
Stephen L. Lewis et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution
Chia-Lin Tseng et al.
GLOBAL SPINE JOURNAL (2017)
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review
Stephanie G. C. Kroeze et al.
CANCER TREATMENT REVIEWS (2017)
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies
ShengFa Su et al.
BMC CANCER (2016)
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Daniel R. Gomez et al.
LANCET ONCOLOGY (2016)
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases
Hania A. Al-Hallaq et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China
ShengFa Su et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer
S. H. Lim et al.
ANNALS OF ONCOLOGY (2015)
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients
C. Collen et al.
ANNALS OF ONCOLOGY (2014)
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer
Allison B. Ashworth et al.
CLINICAL LUNG CANCER (2014)
The oligometastatic state-separating truth from wishful thinking
David A. Palma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature
Allison Ashworth et al.
LUNG CANCER (2013)
Radical Treatment of Non-Small-Cell Lung Cancer Patients with Synchronous Oligometastases Long-Term Results of a Prospective Phase II Trial (Nct01282450)
Dirk De Ruysscher et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
Daniel R. Gomez et al.
PULMONARY MEDICINE (2012)
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Stanley H. Benedict et al.
MEDICAL PHYSICS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Laparoscopic adrenalectomy for isolated adrenal metastasis
Vivian E. Strong et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
The management of respiratory motion in radiation oncology report of AAPM Task Group 76
Paul J. Keall et al.
MEDICAL PHYSICS (2006)